Evaluation of IGF2, KRT14, and KRT20 as Urinary Biomarkers in Patients with Bladder Cancer.

Autor: Rasti A; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Khalili M; Department of Urology, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran., Fakhr Yasseri AM; Shariati Hospital, Alborz University of Medical Sciences, Karaj, Iran., Nasirian N; Department of Pathobiology, School of Medicine, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran., Shirkoohi R; Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Nowroozi MR; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran., Modarressi MH; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Jazyk: angličtina
Zdroj: Reports of biochemistry & molecular biology [Rep Biochem Mol Biol] 2023 Jan; Vol. 11 (4), pp. 710-719.
DOI: 10.52547/rbmb.11.4.710
Abstrakt: Background: Many researchers have tried to identify bladder cancer biomarkers to reduce the need for cystoscopy. The aim of this study was to identify and measure appropriate transcripts in patient urine to develop a non-invasive screening test.
Methods: From February 2020 to May 2022, 49 samples were obtained from Velayat Hospital, Qazvin University of Medical Sciences, Qazvin, Iran. Twenty-two samples were obtained from bladder cancer patients and 27 from bladder cancer-free subjects. RNA was extracted from participant samples, quantitative RT-PCR was performed, and TNP plots were used to assess IGF2 (NCBI Gene ID: 3481), KRT14 (NCBI Gene ID: 3861) and KRT20 (NCBI Gene ID: 54474) expression. For UCSC Xena analysis, Dataset ID: TCGA-BLCA was used to compare transitional cell carcinoma (TCC) and normal samples for survival rates.
Results: IGF and KRT14 were more greatly expressed in patient urine samples than in those of the normal group. However, KRT20 expression did not significantly differ between the two groups. IGF2 had 45.45 and 88.89% sensitivity and specificity, respectively, for detecting TCC in urine samples while KRT14 had 59 and 88.89% sensitivity and specificity, respectively. Also, these results infer that overexpression of IGF would be prognosticators of poor TCC outcomes.
Conclusion: Our study showed that IGF2 and KRT14 are overexpressed in bladder cancer patient urine, and IGF2 could be a potential biomarker for poor prognoses in TCC.
Competing Interests: The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Databáze: MEDLINE
Externí odkaz: